p.41 抽出テキスト

Arnett et al 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

September 10, 2019 Circulation. 2019;140:e596–e646. DOI: 10.1161/CIR.0000000000000678 e636

CLINICAL STATEMENTS AND GUIDELINES S5-3.	 Bress AP, Bellows BK, King JB, et al. Cost-effectiveness of intensive ver-

sus standard blood-pressure control. N Engl J Med. 2017;377:745–55. S5-4.	 Moran AE, Odden MC, Thanataveerat A, et al. Cost-effectiveness of hypertension therapy according to 2014 guidelines. N Engl J Med. 2015;372:447–55. S5-5.	 Park C, Wang G, Durthaler JM, et al. Cost-effectiveness analyses of antihypertensive medicines: a systematic review. Am J Prev Med. 2017;53:S131–42. S5-6.	 Richman IB, Fairley M, Jørgensen ME, et al. Cost-effectiveness of intensive blood pressure management. JAMA Cardiol. 2016;1:872–9. S5-7.	 Heller DJ, Coxson PG, Penko J, et al. Evaluating the impact and costeffectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke. Circulation. 2017;136:1087–98. S5-8.	 Odden MC, Pletcher MJ, Coxson PG, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015;162:533–41. S5-9.	 Heart Protection Study Collaborative Group. Statin cost-effective-

ness in the United States for people at different vascular risk levels. Circ Cardiovasc Qual Outcomes. 2009;2:65–72.

6 CONCLUSION

S6-1.	 Lehr AL, Driver SL, Stone NJ. The ABCDs of lifestyle counseling.

JAMA Cardiol. 2016;1:505–6. APPENDIX 1. SEARCH CRITERIA

1.	 Patnode CD, Evans CV, Senger CA, et al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017;318:175–93. 2.	 LeBlanc ES, Patnode CD, Webber EM, et al. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320: 1172–91. 3.	 Selph S, Dana T, Bougatsos C, et al. Screening for abnormal glucose and type 2 diabetes mellitus: a systematic review to update the 2008 US Preventive Services Task Force Recommendation. Report No. 13-05190- EF-1. Rockville, MD: US Agency for Healthcare Research and Quality, 2015. Available at: http://www.ncbi.nlm.nih.gov/books/NBK293871. Accessed January 5, 2019. 4.	 Patnode CD, Henderson JT, Thompson JH, et al. Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the US Preventive Services Task Force. Ann Intern Med. 2015;163:608–21. 5.	 Guirguis-Blake JM, Evans CV, Senger CA, et al. Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the US Preventive Services Task Force. Ann Intern Med. 2016;164:804–13.

Downloaded from http://ahajournals.org by on October 7, 2026